Cornerstone Therapeutics, Inc. (CRTX) Misses Q3 EPS by 1c, Sales Fall Below Expectations
Tweet
Share
E-mailGet Alerts CRTX Hot Sheet
Price: $1.95 --0%
Financial Fact:
Total other expenses: -1.79M
Today's EPS Names:
HSAI, SYRS, EGRX, More
Financial Fact:
Total other expenses: -1.79M
Today's EPS Names:
HSAI, SYRS, EGRX, More
Join SI Premium – FREE
Cornerstone Therapeutics, Inc. (NASDAQ: CRTX) reported Q3 non-GAAP EPS of $0.13, $0.01 worse than the analyst estimate of $0.14. Revenue for the quarter came in at $25.18 million versus the consensus estimate of $28.39 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna Group plc (KLAR) Tops Q2 EPS by 6c, Beats on Revenue; Offers FY26 Revenue Guidance
- Hesai Group (HSAI) Tops Q1 EPS by 8c
- iQIYI (IQ) Misses Q2 EPS by 21c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
